Resistance trends and risk factors of extended spectrum β-lactamases in Escherichia coli infections in Aleppo, Syria

American Journal of Infection Control

Volumn 41, Issue 7, 2013, Pages 597-600

  Al Assil, Bodour ^a   Mahfoud, Maysa ^a   Hamzeh, Abdul Rezzak ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

ESBL producing E coli; Multidrug resistance; Tigecycline; UTIs

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CATHETERIZATION; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PHENOTYPE; PREVALENCE; RISK FACTOR; SYRIAN ARAB REPUBLIC; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SYRIA; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84879504001     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2012.09.016     Document Type: Article

References (15)

1. S. Kariuki, G. Revathi, J. Corkill, J. Kiiru, J. Mwituria, N. Mirza, and C.A. Hart Escherichia coli from commonly-acquired urinary tract infections resistant to flouroquinolones and extended spectrum β-lactams J Infect Dev Ctries 1 2007 257 262
2. M.H. Wilcox The tide of antimicrobial resistance and selection Int J Antimicrob Agents 34 Suppl 3 2009 S6 10
3. F. Perez, A. Endimiani, K.M. Hujer, and R.A. Bonomo The continuing challenge of ESBLs Curr Opin Pharmacol 7 2007 459 469
4. C. Schultsz, and S. Geerlings Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy Drugs 72 2012 1 16
5. A.D. Harris, J.C. McGregor, J.A. Johnson, S.M. Strauss, A.C. Moore, and H.C. Standiford Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission Emerg Infect Dis 13 2007 1144 1149
6. th edition 2010 McGraw-Hill Medical New York, NY 832
7. Clinical Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. 2010. CLSI document M100-S20 2010 CLSI Wayne [PA]
8. S. Moyo, S. Aboud, M. Kasubi, F.L. Eligius, and Y. Samuel Antimicrobial resistance among producers and non-producers of extended spectrum β-lactamases in urinary isolates at a tertiary Hospital in Tanzania BMC Res Notes 3 2010 34 38
9. T.S. Dimitrov, E.E. Udo, M. Emara, F. Awni, and R. Passadilla Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital Med Princ Pract 13 2004 334 339
10. N. Kashef, G.E. Djavid, and S. Shahbazi Antimicrobial susceptibility patterns of community-acquired uropathogens in Tehran Iran. J Infect Dev Ctries 4 2010 202 206
11. Y.B. Ngwai, M.O. Akpotu, R.E. Obidake, A.A. Sounyo, A. Onanuga, and S.O. Origbo Antimicrobial susceptibility of Escherichia coli and other coliforms isolated from urine of asymptomatic students in Bayelsa State, Nigeria Afr J Microbiol Res 5 2010 184 191
12. D. Sahm, C. Thornsberry, D. Mayfield, M. Jones, and J. Karlowsky Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000 Antimicrob Agents Chemother 45 2001 1402 1406
13. G. Thabit, T. El-Khamissy, M. Ibrahim, and A. Attia Detection of extended-spectrum β-lactamase enzymes (ESBLs) produced by Escherichia coli urinary pathogens at Assiut University Hospital Bull Pharm 34 2011 93 103
14. D.S. Lee, C.B. Lee, and S.J. Lee Prevalence and risk factors for extended spectrum β-lactamase-producing uropathogens in patients with urinary tract infection Korean J Urol 51 2010 94 97
15. H.S. Khanfar, K.M. Bindayna, A.C. Senok, and G.A. Botta Extended spectrum β-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings J Infect Dev Ctries 3 2009 295 299